Schedule 13D ownership disclosure
INSYS THERAPEUTICS INC
Security class unavailable · CUSIP: 45824V209
Event date: 2018-02-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 42,536,080
- Percent of class
- 58.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-18-000279
- Form type
- SC 13D
- Filer
- Insys Therapeutics, Inc.
- CIK
- CIK 1516479
- Filed
- Mar 08, 2018
- Reporting period
- Feb 27, 2018
- Description
- Schedule 13D beneficial ownership